{"AllianceGenome": "3133", "HGNC": "3133", "MIM": "300205", "_id": "10682", "_version": 1, "accession": {"genomic": ["AF196972.1", "AX814436.1", "CH471224.1", "CP068255.2", "KT583889.1", "NC_000023.11", "NC_060947.1", "NG_007452.1"], "protein": ["AAH01549.1", "AAH01572.1", "AAH46501.1", "AIL31429.1", "CAA86068.1", "CAE83482.1", "CAG33096.1", "CAG46891.1", "EAW50773.1", "EAW50774.1", "EAW50775.1", "NP_006570.1", "Q15125.3"], "rna": ["AU128761.1", "BC001549.1", "BC001572.1", "BC046501.1", "CA488777.1", "CR456815.1", "CR542094.1", "KJ921656.1", "NM_006579.3", "Z37986.1"], "translation": [{"protein": "AAH01572.1", "rna": "BC001572.1"}, {"protein": "CAG46891.1", "rna": "CR542094.1"}, {"protein": "AIL31429.1", "rna": "KJ921656.1"}, {"protein": "AAH46501.1", "rna": "BC046501.1"}, {"protein": "NP_006570.1", "rna": "NM_006579.3"}, {"protein": "CAA86068.1", "rna": "Z37986.1"}, {"protein": "AAH01549.1", "rna": "BC001549.1"}, {"protein": "CAG33096.1", "rna": "CR456815.1"}]}, "alias": ["CDPX2", "CHO2", "CPX", "CPXD", "MEND"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2022-09-07T18:00:00.000Z", "disease_label": "MEND syndrome", "gcep": "Intellectual Disability and Autism Gene Curation Expert Panel", "moi": "XL", "mondo": "MONDO:0010498", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_21e97c32-52ae-4331-8788-64d652f20af3-2022-09-07T180000.000Z", "sop": "SOP9"}}, "ec": "5.3.3.5", "ensembl": {"gene": "ENSG00000147155", "protein": ["ENSP00000390031", "ENSP00000405832", "ENSP00000417052"], "transcript": ["ENST00000276096", "ENST00000414061", "ENST00000446158", "ENST00000466461", "ENST00000495186", "ENST00000498425"], "translation": [{"protein": "ENSP00000417052", "rna": "ENST00000495186"}, {"protein": "ENSP00000390031", "rna": "ENST00000446158"}, {"protein": "ENSP00000405832", "rna": "ENST00000414061"}], "type_of_gene": "protein_coding"}, "entrezgene": "10682", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 6.13738231365, "exp_mis": 53.1315076887, "exp_syn": 24.3732433378, "lof_z": 2.45403792745173, "mis_z": 1.28377712695562, "mu_lof": 6.43823196368e-07, "mu_mis": 7.26529714221e-06, "mu_syn": 3.27630887922e-06, "n_lof": 0.0, "n_mis": 34.0, "n_syn": 27.0, "p_li": 0.858629818405411, "p_null": 0.00218955434912991, "p_rec": 0.139180627245459, "syn_z": -0.329847547774848}, "bp": 693, "cds_end": 48386845, "cds_start": 48382159, "n_exons": 4, "nonpsych": {"exp_lof": 5.5095722644, "exp_mis": 48.1352118869, "exp_syn": 22.0502638642, "lof_z": 2.30521216638761, "mis_z": 1.3184171041597, "mu_lof": 6.43823196368e-07, "mu_mis": 7.26529714221e-06, "mu_syn": 3.27630887922e-06, "n_lof": 0.0, "n_mis": 30.0, "n_syn": 23.0, "p_li": 0.845348818890559, "p_null": 0.00334662055488057, "p_rec": 0.15130456055456, "syn_z": -0.127338977094816}, "nontcga": {"exp_lof": 5.5705342248, "exp_mis": 48.3721774861, "exp_syn": 22.1795231441, "lof_z": 2.32825028108394, "mis_z": 1.31605071241435, "mu_lof": 6.43823196368e-07, "mu_mis": 7.26529714221e-06, "mu_syn": 3.27630887922e-06, "n_lof": 0.0, "n_mis": 30.0, "n_syn": 26.0, "p_li": 0.835956277038816, "p_null": 0.00322860707144578, "p_rec": 0.160815115889738, "syn_z": -0.513646286153512}, "transcript": "ENST00000495186.1"}, "exons": [{"cdsend": 48528457, "cdsstart": 48523771, "chr": "X", "position": [[48521807, 48521907], [48523698, 48524072], [48526988, 48527025], [48527154, 48527285], [48528233, 48528716]], "strand": 1, "transcript": "NM_006579", "txend": 48528716, "txstart": 48521807}], "exons_hg19": [{"cdsend": 48386845, "cdsstart": 48382159, "chr": "X", "position": [[48380195, 48380295], [48382086, 48382460], [48385376, 48385413], [48385542, 48385673], [48386621, 48387104]], "strand": 1, "transcript": "NM_006579", "txend": 48387104, "txstart": 48380195}], "generif": [{"pubmed": 17378690, "text": "Molecular analysis of EBP mutations were made."}, {"pubmed": 17498944, "text": "Emopamil binding protein (EBP)-shRNA sequences were designed and tested for their effectiveness."}, {"pubmed": 17949453, "text": "We found two novel (3G-->T and 419-422delTTCT) and one known mutation in the EBP gene. The strong phenotypic variability in our patients suggests that there is no clear genotype-phenotype correlation."}, {"pubmed": 18573709, "text": "two unrelated Thai girls with chondrodysplasia punctata type 2. Mutation analysis by PCR-sequencing the entire coding region of emopamil binding protein(EBP) successfully revealed two potentially pathogenic, novel mutations, c.616G-->T and c.382delC."}, {"pubmed": 18660489, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21931045, "text": "postzygotic mosaicism on an ichthyosiform skin lesion in the mother of a girl with X-linked dominant chondrodysplasia punctata associated with a novel EBP mutation."}, {"pubmed": 22121851, "text": "Results show a clear relationship between abnormal sterol profile and the EBP gene mutation"}, {"pubmed": 24106871, "text": "Elastin binding protein and FKBP65 modulate the kinetics of self-assembly of tropoelastin in an in vitro system."}, {"pubmed": 24459067, "text": "With non-mosaic EBP mutations in males."}, {"pubmed": 24493593, "text": "Report steroidomimetic aminomethyl spiroacetals as novel inhibitors of the enzyme Delta8,7-sterol isomerase in cholesterol biosynthesis."}, {"pubmed": 24700572, "text": "This study expands the current phenotypic spectrum of males with hypomorphic EBP mutations and supports to the hypothesis that there exists an X-linked recessive entity independent of CDPX2."}, {"pubmed": 24915996, "text": "Mutation analysis revealed a heterozygous novel missense mutation, c.204G>T (p.W68C), in exon 2."}, {"pubmed": 31165728, "text": "EBP adopts an unreported fold involving five transmembrane-helices (TMs) that creates a membrane cavity presenting a pharmacological binding site that accommodates multiple different ligands. Mutagenesis studies on specific residues abolish the isomerase activity and decrease the multidrug binding capacity."}, {"pubmed": 31381990, "text": "The human sterol delta(8)-Delta(7) isomerase was expressed in P. pastoris to 200mgL-1.  The membrane protein enzyme could be solubilized readily in dodecyl maltoside. The solubilized protein displayed a symmetric peak on size exclusion chromatography."}, {"pubmed": 32105736, "text": "Thermostabilization of Membrane Proteins by Consensus Mutation: A Case Study for a Fungal Delta8-7 Sterol Isomerase."}], "genomic_pos": {"chr": "X", "end": 48528716, "ensemblgene": "ENSG00000147155", "start": 48521799, "strand": 1}, "genomic_pos_hg19": [{"chr": "HG1436_HG1432_PATCH", "end": 48388115, "start": 48380557, "strand": 1}, {"chr": "X", "end": 48387104, "start": 48379546, "strand": 1}], "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006695", "qualifier": "involved_in", "term": "cholesterol biosynthetic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006695", "pubmed": 9894009, "qualifier": "involved_in", "term": "cholesterol biosynthetic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0008203", "pubmed": 10391219, "qualifier": "involved_in", "term": "cholesterol metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030097", "qualifier": "involved_in", "term": "hemopoiesis"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0033489", "qualifier": "involved_in", "term": "cholesterol biosynthetic process via desmosterol"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0033490", "qualifier": "involved_in", "term": "cholesterol biosynthetic process via lathosterol"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043931", "pubmed": 10391219, "qualifier": "involved_in", "term": "ossification involved in bone maturation"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005635", "pubmed": 10406945, "qualifier": "located_in", "term": "nuclear envelope"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005783", "qualifier": "is_active_in", "term": "endoplasmic reticulum"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005783", "pubmed": 10406945, "qualifier": "located_in", "term": "endoplasmic reticulum"}, {"evidence": "ISM", "gocategory": "CC", "id": "GO:0005789", "pubmed": 7706302, "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0031410", "qualifier": "located_in", "term": "cytoplasmic vesicle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0031965", "qualifier": "located_in", "term": "nuclear membrane"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0000247", "qualifier": "enables", "term": "C-8 sterol isomerase activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0000247", "qualifier": "enables", "term": "C-8 sterol isomerase activity"}, {"category": "MF", "evidence": "EXP", "id": "GO:0004769", "pubmed": [10391218, 10391219], "qualifier": "enables", "term": "steroid delta-isomerase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004769", "qualifier": "enables", "term": "steroid delta-isomerase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004769", "pubmed": [9894009, 10391219], "qualifier": "enables", "term": "steroid delta-isomerase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0004769", "pubmed": 10391219, "qualifier": "enables", "term": "steroid delta-isomerase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [25910212, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": 32296183, "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0047750", "qualifier": "enables", "term": "cholestenol delta-isomerase activity"}]}, "homologene": {"genes": [[3702, 838593], [4530, 4326449], [7955, 436600], [9606, 10682], [9615, 609430], [9913, 515569], [10090, 13595], [10116, 117278], [318829, 2677970]], "id": 4798}, "interpro": [{"desc": "Emopamil-binding protein", "id": "IPR007905", "short_desc": "EBP"}, {"desc": "EXPERA domain", "id": "IPR033118", "short_desc": "EXPERA"}], "ipi": ["IPI00008599", "IPI00642218", "IPI00643669"], "map_location": "Xp11.23", "name": "EBP cholestenol delta-isomerase", "other_names": ["3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase", "3-beta-hydroxysteroid-delta-8,delta-7-isomerase", "Chondrodysplasia punctata-2, X-linked dominant (Happle syndrome)", "D8-D7 sterol isomerase", "cholestenol Delta-isomerase", "delta(8)-Delta(7) sterol isomerase", "emopamil binding protein (sterol isomerase)", "emopamil-binding protein", "sterol 8-isomerase"], "pantherdb": {"HGNC": "3133", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "107822", "ortholog_type": "LDO", "panther_family": "PTHR14207", "taxid": 10090, "uniprot_kb": "P70245"}, {"RGD": "620957", "ortholog_type": "LDO", "panther_family": "PTHR14207", "taxid": 10116, "uniprot_kb": "Q9JJ46"}, {"Ensembl": "ENSGALG00000048205", "ortholog_type": "LDO", "panther_family": "PTHR14207", "taxid": 9031, "uniprot_kb": "A0A3Q3B0X4"}, {"ZFIN": "ZDB-GENE-040718-12", "ortholog_type": "LDO", "panther_family": "PTHR14207", "taxid": 7955, "uniprot_kb": "A0A2R8Q2C6"}, {"dictyBase": "DDB_G0269414", "ortholog_type": "LDO", "panther_family": "PTHR14207", "taxid": 352472, "uniprot_kb": "Q55E32"}, {"TAIR": "2198626", "ortholog_type": "LDO", "panther_family": "PTHR14207", "taxid": 3702, "uniprot_kb": "O48962"}], "uniprot_kb": "Q15125"}, "pathway": {"humancyc": [{"id": "PWY66-3", "name": "cholesterol biosynthesis II (via 24,25-dihydrolanosterol)"}, {"id": "PWY66-341", "name": "cholesterol biosynthesis I"}, {"id": "PWY66-4", "name": "cholesterol biosynthesis III (via desmosterol)"}, {"id": "PWY66-5", "name": "superpathway of cholesterol biosynthesis"}], "kegg": {"id": "hsa00100", "name": "Steroid biosynthesis - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-191273", "name": "Cholesterol biosynthesis"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-6807047", "name": "Cholesterol biosynthesis via desmosterol"}, {"id": "R-HSA-6807062", "name": "Cholesterol biosynthesis via lathosterol"}, {"id": "R-HSA-8957322", "name": "Metabolism of steroids"}], "smpdb": [{"id": "SMP00023", "name": "Steroid Biosynthesis"}, {"id": "SMP00079", "name": "Ibandronate Action Pathway"}, {"id": "SMP00082", "name": "Simvastatin Action Pathway"}, {"id": "SMP00089", "name": "Pravastatin Action Pathway"}, {"id": "SMP00092", "name": "Rosuvastatin Action Pathway"}, {"id": "SMP00095", "name": "Alendronate Action Pathway"}, {"id": "SMP00099", "name": "Lovastatin Action Pathway"}, {"id": "SMP00107", "name": "Zoledronate Action Pathway"}, {"id": "SMP00111", "name": "Cerivastatin Action Pathway"}, {"id": "SMP00112", "name": "Risedronate Action Pathway"}, {"id": "SMP00117", "name": "Pamidronate Action Pathway"}, {"id": "SMP00119", "name": "Fluvastatin Action Pathway"}, {"id": "SMP00131", "name": "Atorvastatin Action Pathway"}, {"id": "SMP00209", "name": "Hypercholesterolemia"}, {"id": "SMP00319", "name": "Lysosomal Acid Lipase Deficiency (Wolman Disease)"}, {"id": "SMP00386", "name": "Desmosterolosis"}, {"id": "SMP00387", "name": "CHILD Syndrome"}, {"id": "SMP00388", "name": "Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)"}, {"id": "SMP00389", "name": "Smith-Lemli-Opitz Syndrome (SLOS)"}, {"id": "SMP00508", "name": "Cholesteryl ester storage disease"}, {"id": "SMP00509", "name": "Hyper-IgD syndrome"}, {"id": "SMP00510", "name": "Mevalonic aciduria"}, {"id": "SMP00511", "name": "Wolman disease"}], "wikipathways": [{"id": "WP4718", "name": "Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways)"}, {"id": "WP4804", "name": "Cholesterol Biosynthesis with Skeletal Dysplasias"}]}, "pdb": ["6OHT", "6OHU"], "pfam": "PF05241", "pharmgkb": "PA27587", "pharos": {"target_id": 12353, "tdl": "Tchem"}, "pir": "B56122", "prosite": "PS51751", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF261795", "relationship": "is"}, {"id": "GNF261796", "relationship": "is"}, {"id": "GNF261797", "relationship": "is"}, {"id": "GNF261798", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF164545", "relationship": "similar to"}, "GNF_hs-Origene": {"id": "GNF035226", "relationship": "similar to"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF082065", "relationship": "is"}, {"id": "GNF082066", "relationship": "is"}, {"id": "GNF082067", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054888", "relationship": "is"}, {"id": "GNF059675", "relationship": "is"}, {"id": "GNF075102", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070737", "relationship": "is"}, {"id": "GNF070738", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF003951", "relationship": "is"}, {"id": "GNF003952", "relationship": "is"}, {"id": "GNF003953", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": [{"id": "GNF236712", "relationship": "is"}, {"id": "GNF236946", "relationship": "is"}, {"id": "GNF242907", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF112275", "relationship": "is"}, {"id": "GNF151916", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000023.11", "NC_060947.1", "NG_007452.1"], "protein": "NP_006570.1", "rna": "NM_006579.3", "translation": {"protein": "NP_006570.1", "rna": "NM_006579.3"}}, "reporter": {"HG-U133_Plus_2": ["202735_at", "213787_s_at", "213789_at", "231320_at"], "HG-U95Av2": "32536_at", "HTA-2_0": "TC0X000253.hg.1", "HuEx-1_0": "3976670", "HuGene-1_1": "8167305", "HuGene-2_1": "17103327"}, "retired": [1037, 139151], "summary": "The protein encoded by this gene is an integral membrane protein of the endoplasmic reticulum. It is a high affinity binding protein for the antiischemic phenylalkylamine Ca2+ antagonist [3H]emopamil and the photoaffinity label [3H]azidopamil. It is similar to sigma receptors and may be a member of a superfamily of high affinity drug-binding proteins in the endoplasmic reticulum of different tissues. This protein shares structural features with bacterial and eukaryontic drug transporting proteins. It has four putative transmembrane segments and contains two conserved glutamate residues which may be involved in the transport of cationic amphiphilics. Another prominent feature of this protein is its high content of aromatic amino acid residues (>23%) in its transmembrane segments. These aromatic amino acid residues have been suggested to be involved in the drug transport by the P-glycoprotein. Mutations in this gene cause Chondrodysplasia punctata 2 (CDPX2; also known as Conradi-Hunermann syndrome). [provided by RefSeq, Jul 2008].", "symbol": "EBP", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414236"}, "unigene": "Hs.30619", "uniprot": {"Swiss-Prot": "Q15125", "TrEMBL": ["C9J719", "A0A024QYX0", "C9JJ78"]}}